The recommended radical hysterectomy with pelvic lymphadenectomy is the standard therapy for young women with stage IA2-IB1 cervical cancer. However, many women diagnosed with cervical cancer have not completed their childbearing. Cervical conization alone is adequate treatment for patients with stage IA1 cervical cancer. Neoadjuvant chemotherapy followed by conization and pelvic lymphadenectomy may be considered an alternative for young women with stage IA2-IB1 cervical cancer who wish to preserve their fertility potential. Successful pregnancies have been reported after these regimens. Patients who choose conservative therapy must maintain close long-term follow-up.